$LASE
Laser Photonics Corp Stock $lase

$lase Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224020049 Filed on May 15, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q1
Revenue	$743.0K	$494.8K	$1.237M
YoY Change	-39.94%	-57.51%	2.06%
Cost Of Revenue	$357.1K	$631.1K	$241.1K
YoY Change	48.11%	8.14%	-19.24%
Gross Profit	$385.9K	-$136.3K	$995.9K
YoY Change	-61.26%	-123.47%	9.02%
Gross Profit Margin	51.93%	-27.55%	80.51%
Selling, General & Admin	$492.9K	$550.6K	$2.144M
YoY Change	-77.02%	-77.16%	384.71%
% of Gross Profit	127.73%		215.33%
Research & Development	$47.69K	$202.3K	$40.25K
YoY Change	18.48%
% of Gross Profit	12.36%		4.04%
Depreciation & Amortization	$185.3K	$187.1K	$83.14K
YoY Change	122.9%	116.54%	-7.58%
% of Gross Profit	48.03%		8.35%
Operating Expenses	$934.3K	$1.160M	$2.228M
YoY Change	-58.06%	-53.53%	314.99%
Operating Profit	-$548.5K	-$1.297M	-$1.232M
YoY Change	-55.47%	-32.33%	-426.98%
Interest Expense		$0.00	$0.00
YoY Change			-100.0%
% of Operating Profit
Other Income/Expense, Net	$2.760K	$30.06K	-$200.1K
YoY Change	-101.38%	-20140.0%	4439.25%
Pretax Income	-$545.7K	-$1.267M	-$1.432M
YoY Change	-61.89%	-33.91%	-480.09%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$545.7K	-$1.267M	-$1.432M
YoY Change	-61.89%	-33.43%	-480.09%
Net Earnings / Revenue	-73.45%	-255.95%	-115.74%
Basic Earnings Per Share	-$0.06		-$0.18
Diluted Earnings Per Share	-$0.06	-$0.14	-$0.18
COMMON SHARES
Basic Shares Outstanding	9.270M shares	8.253M shares	9.009M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.173M	$6.201M	$10.82M
YoY Change	-52.17%	-49.1%	2218.43%
Cash & Equivalents	$5.173M	$6.201M	$10.82M
Short-Term Investments
Other Short-Term Assets	$114.8K	$39.19K	$3.698M
YoY Change	-96.9%
Inventory	$2.167M	$2.278M	$1.951M
Prepaid Expenses
Receivables	$443.3K	$816.4K	$1.747M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.898M	$9.335M	$14.51M
YoY Change	-45.58%	-38.68%	363.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.014M	$952.8K	$652.3K
YoY Change	55.39%	51.76%	-2.83%
Goodwill
YoY Change
Intangibles	$4.196M	$4.280M
YoY Change
Long-Term Investments
YoY Change
Other Assets			$183.1K
YoY Change			4051.07%
Total Long-Term Assets	$5.687M	$5.830M	$4.459M
YoY Change	27.53%	30.38%	5.18%
TOTAL ASSETS
Total Short-Term Assets	$7.898M	$9.335M	$14.51M
Total Long-Term Assets	$5.687M	$5.830M	$4.459M
Total Assets	$13.58M	$15.16M	$18.97M
YoY Change	-28.4%	-23.0%	157.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$306.3K	$223.0K	$420.6K
YoY Change	-27.17%	17.15%	108.22%
Accrued Expenses	$79.01K	$161.5K	$2.096M
YoY Change	-96.23%	-89.41%	1376.72%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change
Total Short-Term Liabilities	$1.472M	$1.520M	$2.516M
YoY Change	-41.49%	-11.42%	195.92%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$163.0K	$163.0K	$397.0K
YoY Change	-58.94%	-66.57%	-31.53%
Total Long-Term Liabilities	$163.0K	$163.0K	$397.0K
YoY Change	-58.94%	-66.57%	-31.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.472M	$1.520M	$2.516M
Total Long-Term Liabilities	$163.0K	$163.0K	$397.0K
Total Liabilities	$1.635M	$1.683M	$2.913M
YoY Change	-43.87%	-23.62%	103.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.229M	-$5.683M	-$728.2K
YoY Change	755.43%	680.48%	-212.72%
Common Stock	$92.70K	$92.53K	$78.78K
YoY Change	17.67%	17.45%	61.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$25.24K	$25.24K
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.95M	$13.48M	$16.06M
YoY Change
Total Liabilities & Shareholders Equity	$13.58M	$15.16M	$18.97M
YoY Change	-28.4%	-23.0%	157.51%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q1
OPERATING ACTIVITIES
Net Income	-$545.7K	-$1.267M	-$1.432M
YoY Change	-61.89%	-33.43%	-480.09%
Depreciation, Depletion And Amortization	$185.3K	$187.1K	$83.14K
YoY Change	122.9%	116.54%	-7.58%
Cash From Operating Activities	-$866.3K	-$1.925M	-$1.315M
YoY Change	-34.14%	129.29%	-821.93%
INVESTING ACTIVITIES
Capital Expenditures	$161.8K	$159.2K	$50.80K
YoY Change	218.41%	314.88%	-1309.52%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$161.8K	-$159.2K	-$50.80K
YoY Change	218.41%	314.88%	1110.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	-25.24K	$0.00
YoY Change		-100.2%	-100.0%
NET CHANGE
Cash From Operating Activities	-$866.3K	-1.925M	-$1.315M
Cash From Investing Activities	-$161.8K	-159.2K	-$50.80K
Cash From Financing Activities	$0.00	-25.24K	$0.00
Net Change In Cash	-$1.028M	-2.109M	-$1.366M
YoY Change	-24.75%	-117.65%	815.4%
FREE CASH FLOW
Cash From Operating Activities	-$866.3K	-$1.925M	-$1.315M
Capital Expenditures	$161.8K	$159.2K	$50.80K
Free Cash Flow	-$1.028M	-$2.084M	-$1.366M
YoY Change	-24.75%	137.41%	-832.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q1	LASE	Distribution To Affiliate DistributionToAffiliate		usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
CY2023Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment		usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements		usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt		usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt		usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2024Q1	LASE	Share Issued For Purchase Of License ShareIssuedForPurchaseOfLicense		usd
CY2023Q1	LASE	Share Issued For Purchase Of License ShareIssuedForPurchaseOfLicense		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	us-gaap	Interest Paid InterestPaid		usd
CY2023Q1	us-gaap	Interest Paid InterestPaid		usd
CY2024Q1	LASE	Stock Issued During Period Value Compensation Gross StockIssuedDuringPeriodValueCompensationGross		usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	443309	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2167000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	114757	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	7898191	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1013638	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4195597	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	477363	usd
CY2024Q1	us-gaap	Assets Assets	13584789	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	306302	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	772686	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	314373	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	79007	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1472368	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162991	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	162991	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1635359	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9253419	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9253419	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7878419	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7878419	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	92703	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18110923	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6228956	usd
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	25240	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11949430	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13584789	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	742991	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	357123	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	269897	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	385868	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	406295	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	136610	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	262925	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	356265	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	575866	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	185316	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	83137	usd
CY2024Q1	us-gaap	Salaries And Wages SalariesAndWages	208455	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	343702	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47691	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40254	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	934338	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1305882	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-548470	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-899588	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2760	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-358017	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-545709	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1257605	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-545709	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1257605	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9270425	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9008910	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-545709	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1257605	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	33336	usd
CY2024Q1	LASE	Distribution To Affiliate DistributionToAffiliate	1019687	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	185316	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	83137	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-373055	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-319123	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-110816	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	228129	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	75565	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	98942	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	83261	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	218608	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-82531	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-351500	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	71453	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-866257	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1315308	usd
CY2024Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	2869	usd
CY2023Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1399	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1	usd
CY2024Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	4095	usd
CY2024Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	3738	usd
CY2023Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	49402	usd
CY2024Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	151052	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-161754	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50801	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1028011	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1366109	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6201137	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12181799	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5173126	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10815690	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13481492	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-545709	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	33335	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1019687	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11949430	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17131489	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1257605	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1257605	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	15873884	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	862941	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	882353	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1033104	usd
CY2024Q1	LASE	Inventory Sales Demo InventorySalesDemo	210030	usd
CY2023Q4	LASE	Inventory Sales Demo InventorySalesDemo	162958	usd
CY2024Q1	us-gaap	Deposits Deposits	5039472	usd
CY2024Q1	LASE	Deposits Description DepositsDescription	The terms on this CD if flexible, having a term of 9 months that automatically renews, Full balance and interest can be withdrawn prior to maturity. A penalty of 7 days interest will be imposed for early withdrawals within the first 6 days of the account term.
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	443309	usd
CY2024Q1	LASE	Allowance Estimated Credit Losses AllowanceEstimatedCreditLosses	183380	usd
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	947647	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	151186	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	243029	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	24216	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	24216	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2167000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2277816	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	830883	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	510132	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1013638	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1115025	usd
CY2024Q1	LASE	Property Plant And Equipment Estimated Useful Life PropertyPlantAndEquipmentEstimatedUsefulLife	P15Y
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	809617	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	526034	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4195597	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2882236	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	79847	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	90609	usd
CY2024Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	306301	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	223040	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	772686	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	701234	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-866257	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1315308	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-161754	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50801	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1028011	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1366109	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	4688695	shares
CY2022Q4	us-gaap	Debt Conversion Original Debt Interest Rate Of Debt DebtConversionOriginalDebtInterestRateOfDebt	0.961	pure
CY2023Q4	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.595	pure
CY2021Q4	us-gaap	Variable Lease Payment VariableLeasePayment	15109	usd
CY2021Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	25109	usd
CY2022Q4	us-gaap	Variable Lease Payment VariableLeasePayment	14805	usd
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	597143	usd
CY2020Q1	LASE	Operating Lease Liability Amount OperatingLeaseLiabilityAmount	434153	usd
CY2020Q1	LASE	Operating Lease Liability Non Current Amount OperatingLeaseLiabilityNonCurrentAmount	162990	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	434153	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	162990	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	597143	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	17000	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-020049-index-headers.html	Edgar Link	pending
0001493152-24-020049-index.html	Edgar Link	pending
0001493152-24-020049.txt	Edgar Link	pending
0001493152-24-020049-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
lase-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lase-20240331_def.xml	Edgar Link	unprocessable
lase-20240331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
lase-20240331_pre.xml	Edgar Link	unprocessable
lase-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LASE
Laser Photonics Corp Stock $lase

2024 Q1 Form 10-Q Financial Statement

#000149315224020049 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LASE Laser Photonics Corp Stock $lase

2024 Q1 Form 10-Q Financial Statement

#000149315224020049 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LASE
Laser Photonics Corp Stock $lase